Maria-del-Carmen Silva-Lucero

Dr. Maria-del-Carmen Silva-Lucero

UNAM, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2022 in Cells
Verified
Journal Article
Open access
PDF file
Laura Gómez-VirgilioLaura Gómez-Virgilio
Laura Gómez-Virgilio
Maria-del-Carmen Silva-LuceroMaria-del-Carmen Silva-Lucero
Maria-del-Carmen Silva-Lucero
DFDiego-Salvador Flores-Morelos
Diego-Salvador Flores-Morelos
JGJazmin Gallardo-Nieto
Jazmin Gallardo-Nieto
Gustavo Lopez-ToledoGustavo Lopez-Toledo
Gustavo Lopez-Toledo
Maria-del-Carmen Cardenas-AguayoMaria-del-Carmen Cardenas-Aguayo
Maria-del-Carmen Cardenas-Aguayo
Autophagy is a highly conserved lysosomal degradation pathway active at basal levels in all cells. However, under stress conditions, such as a lack of nutrients or trophic factors, it works as a survival mechanism that allows the generation of metabolic precursors for the proper functioning of the cells until the nutrients are available. Neurons, as post-mitotic cells, depend largely on autophagy to maintain cell homeostasis to get rid of damaged and/or old organelles and misfolded or aggregated proteins. Therefore, the dysfunction of this process contributes to the pathologies of many human diseases. Furthermore, autophagy is highly active during differentiation and development. In this review, we describe the current knowledge of the different pathways, molecular mechanisms, factors that induce it, and the regulation of mammalian autophagy. We also discuss its relevant role in development and disease. Finally, here we summarize several investigations demonstrating that autophagic abnormalities have been considered the underlying reasons for many human diseases, including liver disease, cardiovascular, cerebrovascular diseases, neurodegenerative diseases, neoplastic diseases, cancers, and, more recently, infectious diseases, such as SARS-CoV-2 caused COVID-19 disease.

1 May 2016 in Neuroscience
Verified
Journal Article
Closed access
LOL. Ortiz-López
L. Ortiz-López
BMB. Márquez-Valadez
B. Márquez-Valadez
AGA. Gómez-Sánchez
A. Gómez-Sánchez
Maria-del-Carmen Silva-LuceroMaria-del-Carmen Silva-Lucero
Maria-del-Carmen Silva-Lucero
MTM. Torres-Pérez
M. Torres-Pérez
GRGerardo Bernabe Ramirez-Rodriguez
Gerardo Bernabe Ramirez-Rodriguez

29 July 2018 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
PLPatricia López
Patricia López
MTMonica Sanchez Tapia
Monica Sanchez Tapia
CPClaudia Perez‐Cruz
Claudia Perez‐Cruz
LVLaura Alejandra Velazquez-Villegas
Laura Alejandra Velazquez-Villegas
TSTauqeerunnisa Syeda
Tauqeerunnisa Syeda
ATArmando Tovar
Armando Tovar

12 February 2013 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
MSMitzi Paola Santoyo-Sanchez
Mitzi Paola Santoyo-Sanchez
Maria-del-Carmen Silva-LuceroMaria-del-Carmen Silva-Lucero
Maria-del-Carmen Silva-Lucero
LALaura Arreola-Mendoza
Laura Arreola-Mendoza
OBOlivier Christophe Barbier
Olivier Christophe Barbier

29 August 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
Laura Gómez-VirgilioLaura Gómez-Virgilio
Laura Gómez-Virgilio
MVMireya Velazquez-Paniagua
Mireya Velazquez-Paniagua
LCLucero Cuazozon-Ferrer
Lucero Cuazozon-Ferrer
Maria-del-Carmen Silva-LuceroMaria-del-Carmen Silva-Lucero
Maria-del-Carmen Silva-Lucero
AGAndres-Ivan Gutierrez-Malacara
Andres-Ivan Gutierrez-Malacara
Maria-del-Carmen Cardenas-AguayoMaria-del-Carmen Cardenas-Aguayo
Maria-del-Carmen Cardenas-Aguayo
This review article focuses on von Hippel–Lindau (VHL) disease, a rare genetic disorder characterized by the development of tumors and cysts throughout the body. It discusses the following aspects of the disease. Genetics: VHL disease is caused by mutations in the VHL tumor suppressor gene located on chromosome 3. These mutations can be inherited or occur spontaneously. This article details the different types of mutations and their associated clinical features. Pathophysiology: The underlying cause of VHL disease is the loss of function of the VHL protein (pVHL). This protein normally regulates hypoxia-inducible factors (HIFs), which are involved in cell growth and survival. When pVHL is dysfunctional, HIF levels become elevated, leading to uncontrolled cell growth and tumor formation. Clinical Manifestations: VHL disease can affect various organs, including the brain, spinal cord, retina, kidneys, pancreas, and adrenal glands. Symptoms depend on the location and size of the tumors. Diagnosis: Diagnosis of VHL disease involves a combination of clinical criteria, imaging studies, and genetic testing. Treatment: Treatment options for VHL disease depend on the type and location of the tumors. Surgery is the mainstay of treatment, but other options like radiation therapy may also be used. Challenges: This article highlights the challenges in VHL disease management, including the lack of effective therapies for some tumor types and the need for better methods to monitor disease progression. In conclusion, we emphasize the importance of ongoing research to develop new and improved treatments for VHL disease.

22 December 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
TSTauqeerunnisa Syeda
Tauqeerunnisa Syeda
MTMonica Sanchez Tapia
Monica Sanchez Tapia
IOItzel Orta
Itzel Orta
OGOmar Granados-Portillo
Omar Granados-Portillo
LPLizbeth Pérez-Jimenez
Lizbeth Pérez-Jimenez
Claudia Perez CruzClaudia Perez Cruz
Claudia Perez Cruz
Obesity is associated with cognitive deficit and liver alterations; however, it remains unclear whether a combination of functional foods could reverse cognitive damage and to what extent it would be associated with changes in gut microbiota and liver. With this aim, male Wistar rats were fed a high-fat-5%sucrose diet (HFS) for 4 mo. And were then fed for 1 mo. with bioactive foods. At the end of this period, liver, serum, feces, intestine, and brain samples were taken. Body composition, energy expenditure, LPS, hormones, intraperitoneal glucose tolerance test, behavioral tests, and gut microbiota were evaluated. We showed that male rats fed high-fat-sucrose diet developed gut microbiota dysbiosis, increased in body fat, decreased antioxidant activity, decreased brain neuropeptide Y, increased the number of astrocytes and activated microglia, along with reduced spine density associated with deficits in working memory. Ingestion of a combination of nopal, soy protein, curcumin, and chia seed oil (bioactive foods) for three months was associated with an increase in a cluster of bacteria with anti-inflammatory capacity, a decrease in serum LPS levels and an increase in serum eicosapentaenoic acid (EPA) with neuroprotective properties. In the liver, ingestion of bioactive food significantly increased antioxidant enzymes, decreased lipogenesis, reduced inflammation mediated by the TLR4-TNFα pathway along with a decrease in body fat, glucose intolerance, and metabolic inflexibility. Finally, neuroinflammation in the brain was reduced and working memory improved. Our study demonstrates that consumption of bioactive foods was associated with reduced liver, brain, and gut microbiota alterations in obese rats.